# Structured Dashboard: ABRIDGE

Generated: 2025-11-06T10:27:21.906959
Source: Structured Payload (data/payloads/abridge.json)

---

## Company Overview
- **Legal Name:** Abridge, Inc.
- **Brand Name:** Abridge
- **Website:** [abridge.com](https://www.abridge.com/)
- **Headquarters:** Pittsburgh, PA, USA
- **Founded Year:** 2019
- **Categories:** Generative AI, Healthcare Technology, Clinical Documentation, AI for Healthcare, Natural Language Processing

## Business Model and GTM
- **Active Products:**
  - Abridge AI Platform: Generative AI Platform for Clinical Conversations, providing clinically useful and billable AI notes at the point of care, integrated directly into EHR workflows.
  - Abridge Contextual Reasoning Engine: Leading healthcare AI infrastructure, powering the most trusted billable, clinically useful, and compliant notes at the point of care.
- **Pricing Tiers:** Free, Pro, Enterprise
- **Notable Customers:** Johns Hopkins, Kaiser Permanente, Duke, Mayo Clinic
- **Hiring Focus:** Engineering, Sales, Marketing

## Funding & Investor Profile
- **Total Raised (USD):** Not disclosed
- **Last Disclosed Valuation (USD):** Not disclosed
- **Last Round Name:** Not disclosed
- **Last Round Date:** Not disclosed
- **Recent Events:**
  - **Funding announcement for Real Time Prior Authorization** on August 12, 2025
  - **Partnership with AltaMed Health Services Corporation** on April 29, 2025
  - **Sharp HealthCare Chooses Abridge for Clinical Documentation** on April 10, 2025

## Growth Momentum
- **Headcount Total:** 100
- **Headcount Growth Percentage:** 50.0%
- **Job Openings Count:** 15
- **Headcount Velocity:** Rapid
- **Products Released in Last 12 Months:** 5
- **Geography Expansion:** Europe, Asia-Pacific
- **Geography Expansion Rate:** Moderate
- **Positive Signals:** Partnership with Kaiser Permanente, Raised $10M funding, Launched new AI feature
- **Negative Signals:** None

## Visibility & Market Sentiment
- **Customer Quality Score:** Enterprise
- **Churn Signals:** Not disclosed
- **Regulatory Exposure:** GDPR
- **Leadership Stability:** Stable
- **Leadership Changes in Last 12 Months:** 1
- **Transparency Score:** 92.0 (High)
- **Marketing Claims:** The company states it offers "Enterprise AI for clinical conversations" and is "Trusted by leading healthcare systems."

## Risks and Challenges
- **Risk Score:** 35.0 (Medium)
- **Key Challenges:**
  - Market competition
  - Regulatory compliance

## Outlook
- The company appears to be on a growth trajectory with a strong focus on expanding its product offerings and geographical presence. The leadership team is stable, and there are no significant negative signals reported. The company is well-positioned in the healthcare AI market, leveraging partnerships with major healthcare systems.

## Disclosure Gaps
- • Revenue figures not disclosed
- • Customer count not available
- • Specific details on funding amounts and valuation not disclosed
- • No case studies provided for claims of enterprise customers